FDHT PET and Bicalutamide in Metastatic Breast Cancer

NCT02697032 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

22

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: Bicalutamide
PROCEDURE: FDHT PET

Sponsor

University Medical Center Groningen